Brian W. Ellis
Three years ago, the Department of Health published an executive letter, EL(94)94,1 giving an initial response to the question of the relationship between commercial organizations and the NHS in the area of disease management. That document was seen by many as somewhat rigorous, and was blamed for stifling further evolution of partnerships between the pharmaceutical industry and the NHS. More advice in the arena of primary care was offered in the White Paper Choice and Opportunity in 1996,2 but further guidance was promised; it was due a year ago. The matter seems to have been 'kicked into touch' by the previous administration prior to last year's election. If the Department of Health is to give direction, it needs to have an agenda which is visible to all. Too often, it is left to the discretion of Health Authorities or even providers to find their own solutions to problems that affect everyone in the Health Service.
A similar story has unfolded over the last 20 years since computing began to evolve in the Health Service. It was clear from the start that while there was a pressing need to 'administer' the activity of health care, there was also a need for doctors to have access to clinical systems with which they could run their clinical service, produce clinical discharges for CPs, indulge in audit and undertake research. What happened? The lack of direction through the late 1980s and early 1990s allowed the evolution of numerous, different patient administration systems (PAS). These hospital systems were incompatible with each other, so it was difficult for purchasers to compare data from different hospitals. The advice given to hospitals intending to procure a PAS was to match 'local requirements' to the systems available; this suggested the incredible assumption that administering patients in one part of the country was different from that in another. At one point, there were more 'approved' PAS systems on the market than were financially sustainable by the NHS. Some of these PAS suppliers became insolvent or moved to different markets, leaving their old customers unsupported. There was little or no central interest or resource available for clinical systems. However, we did see the emergence of small software houses that developed clinical systems; they did at least produce 'what the doctor ordered', but they were mostly 'stand alone'. Thus, clinicians, if they were lucky enough to have the money, had a system that required data entry for patient details and activity separate from the PAS. The result was incompatible activity profiles between clinicians and their managers. There was little incentive for these clinical system suppliers to spend huge sums of money effecting interfaces to the many PAS systems. What was needed then, and is still needed by clinicians and their managers now, are flexible frontend clinical systems integrated into PAS systems.
What has all this to do with managed care? First, we must learn from this lack of direction and the many other disasters, operational and financial, which surround health care information technology (IT) in the UK. We must ensure clear central direction of well-considered policy. Second, IT remains a fundamental requirement for many of the tools of integrated care. Health economists are calling increasingly for clinicians to deliver value for money and to undertake cost-effective treatment based on audit and 'evidence-based medicine'. We cannot do that without the IT infrastructure.
Peter Calcraft, in his article on disease management and managed care (pp. 55-58), touches on the potential of clinical computing. He paints a scenario we have seen depicted before; that of the electronic patient record, direct data input using hand-held devices at the bedside, semi-automated prescriptions and direct access to radiological and other images. More important for integrated care is the potential to build in facilities to support decision-making, prevent prescribing malpractice and support care pathways. An essential component of such a system would be features, such as care pathways, that would enhance patient care, contain cost and reduce risk. Such a package sounds Utopian.
Why are not all our managers rushing at the prospect? I suspect the answer lies in the generally
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held view among managers that computers are essential for the running and organization of the Health Service (i.e., they need them) but a luxury for clinicians (they can do without them). However, it has to be admitted that the investment (both human and financial) required in hardware and software to achieve these solutions is considerable, especially when judged against the pitifully small investment in IT made by most hospitals. Surely the time is now ripe for carefully planned pilots of IT applications to support clinical care, especially in the realms of integrated care projects.
We now need the government to grasp the nettle and tackle these difficult issues. Let us have debate and carefully evaluated policies emerging that will allow us to sustain the health care system well into the millcnium,
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